Publicaciones (177) Publicaciones de FRANCISCO PURROY GARCIA

2023

  1. Association of Time of Day with Outcomes among Patients Triaged for a Suspected Severe Stroke in Nonurban Catalonia

    Stroke, Vol. 54, Núm. 3, pp. 770-780

  2. C-Reactive Protein, Interleukin-6, and Vascular Recurrence After Stroke: An Individual Participant Data Meta-Analysis

    Stroke, Vol. 54, Núm. 5, pp. 1289-1299

  3. Clinical complications after a traumatic brain injury and its relation with brain biomarkers

    Scientific Reports, Vol. 13, Núm. 1

  4. Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population

    International Journal of Stroke, Vol. 18, Núm. 2, pp. 229-236

  5. First pass effect in posterior circulation occlusions: Analysis from the CICAT registry

    International Journal of Stroke, Vol. 18, Núm. 2, pp. 221-228

  6. Influence of vascular imaging acquisition at local stroke centers on workflows in the drip-n-ship model: A RACECAT post hoc analysis

    Journal of NeuroInterventional Surgery, Vol. 16, Núm. 2, pp. 143-150

  7. Lipidomic signature of stroke recurrence after transient ischemic attack

    Scientific Reports, Vol. 13, Núm. 1

  8. Platelet levels and age are determinants of survival after mild–moderate TBI: A prospective study in Spain

    Frontiers in Public Health, Vol. 11

  9. Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study

    Scientific Reports, Vol. 13, Núm. 1

  10. Reperfusion treatment in acute ischaemic stroke due to cervical and cerebral artery dissection: results of a Spanish national multicentre study

    Neurologia, Vol. 38, Núm. 6, pp. 412-418

  11. SARS-CoV-2 infection might be a predictor of mortality in intracerebral hemorrhage

    Journal of the Neurological Sciences, Vol. 444

  12. Sex and gender differences in acute stroke care: metrics, access to treatment and outcome. A territorial analysis of the Stroke Code System of Catalonia

    European Stroke Journal, Vol. 8, Núm. 2, pp. 557-565

  13. The influence of organisational management on door-to-needle times for fibrinolytic treatment

    Neurologia, Vol. 38, Núm. 5, pp. 313-318